Skip to content

PACS Group PACS Equity method investments (Note 11)

Equity method investments (Note 11) at other companies

Sabra Healthcare logo
Sabra HealthcareSBRA
HCA Healthcare logo
HCA HealthcareHCA
GHC
Graham HoldingsGHC
American Healthcare REIT logo
American Healthcare REITAHR
ResMed logo
ResMedRMD

Other financials

Income statement

See full
Revenue$1.4B+11.2%
Gross profit$346.0M+36.5%
Operating income$120.0M+149%
Net income$80.7M+183%
EPS (diluted)$0.50+194%

Balance sheet

See full
Cash & equivalents$273.7M-5.8%
Total debt$3.5B-3.2%
Total equity$1.0B+38.2%
Total assets$5.7B+3.1%

Cash flow

See full
Operating cash flow$236.3M+57.3%
CapEx$21.8M+23.2%
Free cash flow$214.5M+61.9%

Valuation

See full
Market cap$5.79B+189%

Profitability

See full
Gross margin23%+3.7pp
Operating margin7%+4.6pp
Net margin4.5%+3.4pp
FCF margin7.7%

Returns & leverage

See full
Return on equity27.3%+15.8pp
Debt / equity3.3×-1.4×
Current ratio0.0×

Where this comes from

Reported directly by PACS Group in its filing.

Tagged under the XBRL concept us-gaap:EquityMethodInvestments.

The official record: PACS Group’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about PACS Group's equity method investments (note 11).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PACS Group's equity method investments (note 11)?
PACS Group (PACS) reported equity method investments (note 11) of $29.82M in Q1 2026.
How has PACS Group's equity method investments (note 11) changed year-over-year?
PACS Group's equity method investments (note 11) decreased by 16.2% year-over-year, from $35.57M to $29.82M.
What is the long-term trend for PACS Group's equity method investments (note 11)?
Over 2 years (2023 to 2025), PACS Group's equity method investments (note 11) has grown at a 57.8% compound annual growth rate (CAGR), from $12.36M to $30.8M.